Clinical Trials Browser

INDUSTRY × grapiprant × Gastrointestinal × Clear all

NCT03658772 2023-10-24

Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Microsatellite Stable Colorectal Cancer